EV
Insider
Eric Venker
President & Immunovant CEOEric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $14.5M of ROIV (851,383 sh across 3 lots, as filed), executed Oct 15 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$90.2M
shares × price, as filed
Last traded
Aug 28
Filed Sep 1
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $155.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
16 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$25.5M1,711,000 sh across 4 lots
Exec Sep 19 2025
Filed Sep 23 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.2M
100,000 sh × $11.72
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.2M
100,000 sh × $11.52
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.1M
100,000 sh × $11.45
Exec Jun 20 2025
Filed Jun 24 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $11.2M
1,000,000 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.1M
100,000 sh × $10.95
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.0M
100,000 sh × $10.22
Exec Apr 21 2025
Filed Apr 22 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $8.2M
750,000 sh across 2 lots
Exec Mar 20 2025
Filed Mar 24 2025 · 5:30 PM ET More filings →